EICHOR
● Completed
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Condition: Cognition Disorders · Sponsor: Eli Lilly and Company
About this study
The purpose of this study is to test whether an investigational drug called solanezumab can slow the progression of memory problems associated with brain amyloid (protein that forms plaques in the brains of people with Alzheimer Disease \[AD\]).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (68)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Banner Health Research Institute | Phoenix, Arizona, United States | — |
| Barrow Neurological Institute | Phoenix, Arizona, United States | — |
| Banner Sun Health Research Institute | Sun City, Arizona, United States | — |
| Institute for Memory Impairment & Neurological Disorders | Irvine, California, United States | — |
| University of California - San Diego | La Jolla, California, United States | — |
| University of Southern California School of Medicine | Los Angeles, California, United States | — |
| University of California - Los Angeles | Los Angeles, California, United States | — |
| Univ of California Irvine College of Medicine | Orange, California, United States | — |
| Veterans Affairs Medical Center Palo Alto | Palo Alto, California, United States | — |
| Sutter Medical Group | Sacramento, California, United States | — |
| Univ of California San Francisco | San Francisco, California, United States | — |
+ 56 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02008357